This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kempharm Denmark A/s. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Marco Poppe: Innovator in Pharmaceutical Processes
Introduction
Marco Poppe is a notable inventor based in Linz, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of arimoclomol citrate and its intermediates. His work is essential for advancing therapeutic options in various medical applications.
Latest Patents
Marco Poppe holds a patent for "Processes for preparing arimoclomol citrate and intermediates thereof." This patent outlines a process for preparing arimoclomol, arimoclomol citrate, and key intermediates, such as ORZY-01. The disclosure also details methods for producing high-purity arimoclomol citrate and its applications.
Career Highlights
Marco Poppe is currently employed at Kempharm Denmark A/S, where he continues to innovate in pharmaceutical processes. His expertise in this area has positioned him as a valuable asset to his company and the industry at large.
Collaborations
Some of Marco's coworkers include Mark Read and Andreas Pelz, who contribute to the collaborative environment that fosters innovation at Kempharm Denmark A/S.
Conclusion
Marco Poppe's work in the preparation of arimoclomol citrate showcases his dedication to advancing pharmaceutical science. His contributions are vital for the development of new therapeutic methods, and his patent reflects his innovative spirit.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile